Ad-hoc | 6 February 2003 08:53
Eckert & Ziegler AG
english
Eckert & Ziegler AG: Sale of Production Line
Ad-hoc-announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————–
Eckert & Ziegler AG: Sale of Production Line and U.S. Business for Permanent
Prostate Cancer Implants
Berlin, 06.02.2003. Eckert & Ziegler Strahlen- und Medizintechnik AG, a
specialist for radioactive components for medical and industrial applications
located in Berlin, Germany, yesterday executed a comprehensive agreement with
the Atlanta-based Theragenics Corporation (U.S.A) about the transfer and
installation of an automated production line, the sale of parts of her U.S.
business, and the delivery of permanent implants for the treatment of prostate
cancer. In addition, both parties signed a distribution agreement that will
allow BEBIG Isotopen- und Medizintechnik GmbH, an subsidiary of EZAG, to
distribute Theragencis Palladium seeds in Europe.
“The agreement allows EZAG to realize value from its historically under-
developed U.S. business, which has recently come under consolidation pressure
due to the bankruptcy of a distributor and changes in reimbursement rules”,
explained Dr. Andreas Eckert, the CEO of EZAG. “In addition, it confirms the
groups leading position as an innovative equipment manufacturer, and strengthens
BEBIG’s European market presence through the extension of its product portfolio
to Palladium.”
The implementation of the agreement is expected to result in an after tax
earning increase for EZAG during the next two years of about 0.35 and 0.25 EUR
per share respectively.
The Board of Directors
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Strasse 10, D – 13125 Berlin,www.ezag.com
Tel.: +49 (0) 30 / 94 10 84-138
end of ad-hoc-announcement (c)DGAP 06.02.2003
——————————————————————————–
WKN: 565970; ISIN: DE0005659700; Index:
Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Düsseldorf, Hamburg,
Hannover, Stuttgart
060853 Feb 03